Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections

Abroad (travel likely)RecruitingPHASE3

Conditions

Cytomegalovirus Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Marianne LERUEZ-VILLE, MD, PhD

    Study Chair

    Virology laboratory- reference national Lab for CMV infection -Hôpital Necker Enfants malades, Paris

  • Pierre FRANGE, MD, PhD

    Principal Investigator

    Assistance Publique Hôpitaux Paris